The Beauty Health Company (NASDAQ:SKIN) Given Consensus Recommendation of “Hold” by Analysts

Shares of The Beauty Health Company (NASDAQ:SKIN) have been assigned a consensus rating of “Hold” from the six analysts that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $2.55.

Several brokerages have commented on SKIN. Stifel Nicolaus cut their target price on Beauty Health from $4.00 to $2.00 and set a “hold” rating on the stock in a research note on Friday, July 26th. Canaccord Genuity Group increased their target price on Beauty Health from $1.25 to $1.75 and gave the company a “hold” rating in a research note on Wednesday. Finally, Piper Sandler reissued an “underweight” rating and set a $1.00 price target (down from $1.50) on shares of Beauty Health in a report on Friday, August 9th.

Hedge Funds Weigh In On Beauty Health

Institutional investors have recently bought and sold shares of the stock. Federated Hermes Inc. raised its holdings in Beauty Health by 349,616.0% in the 2nd quarter. Federated Hermes Inc. now owns 370,699 shares of the company’s stock worth $712,000 after purchasing an additional 370,593 shares during the period. Cohen Capital Management Inc. raised its holdings in Beauty Health by 344.1% in the 3rd quarter. Cohen Capital Management Inc. now owns 572,848 shares of the company’s stock worth $825,000 after purchasing an additional 443,859 shares during the period. Mirae Asset Global Investments Co. Ltd. bought a new position in Beauty Health in the 1st quarter worth $200,000. Russell Investments Group Ltd. bought a new position in Beauty Health in the 1st quarter worth $279,000. Finally, Caprock Group LLC bought a new position in Beauty Health in the 2nd quarter worth $38,000. 93.26% of the stock is owned by institutional investors.

Beauty Health Stock Performance

Shares of SKIN opened at $1.85 on Thursday. The business’s fifty day simple moving average is $1.57 and its two-hundred day simple moving average is $1.89. The company has a current ratio of 6.49, a quick ratio of 5.47 and a debt-to-equity ratio of 7.96. Beauty Health has a 12 month low of $0.91 and a 12 month high of $5.17. The company has a market cap of $229.44 million, a price-to-earnings ratio of -4.40 and a beta of 0.90.

About Beauty Health

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.